Overview Fundamentals API Earnings EOD API Sample Code Pricing

Rani Therapeutics Holdings Inc (RANI NASDAQ) stock market data APIs

$3.3 0.22(7.1%) as of July 19, 2024
Price chart is built with Anychart

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.

Rani Therapeutics Holdings Inc Financial Data Overview

159 M
26 304 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'RANI',
Type: 'Common Stock',
Name: 'Rani Therapeutics Holdings Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG011R6PZ44',
CIK: '1856725',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-07-30',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,

Rani Therapeutics Holdings Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -62 735 000
  • Earnings Per Share -1.29
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Rani Therapeutics Holdings Inc Earnings via APIs

  • Latest Release 2024-05-06
  • EPS/Forecast -0.2

Get Rani Therapeutics Holdings Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?